Antiinflammatory properties of HDL

被引:1108
作者
Barter, PJ
Nicholls, S
Rye, KA
Anantharamaiah, GM
Navab, M
Fogelman, AM
机构
[1] Heart Res Inst, Sydney, NSW 2050, Australia
[2] Univ Alabama Birmingham, Atherosclerosis Res Unit, Dept Med, Birmingham, AL 35294 USA
[3] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90024 USA
关键词
antiinflammatory; antioxidant; atherosclerosis; high-density lipoprotein;
D O I
10.1161/01.RES.0000146094.59640.13
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
There are several well-documented functions of high-density lipoprotein (HDL) that may explain the ability of these lipoproteins to protect against atherosclerosis. The best recognized of these is the ability of HDL to promote the efflux of cholesterol from cells. This process may minimize the accumulation of foam cells in the artery wall. However, HDL has additional properties that may also be antiatherogenic. For example, HDL is an effective antioxidants. The major proteins of HDL, apoA-I and apoA-II, as well as other proteins such as paraoxonase that cotransport with HDL in plasma, are well-known to have antioxidant properties. As a consequence, HDL has the capacity to inhibit the oxidative modification of low-density lipoprotein (LDL) in a process that reduces the atherogenicity of these lipoproteins. HDL also possesses other antiinflammatory properties. By virtue of their ability to inhibit the expression of adhesion molecules in endothelial cells, they reduce the recruitment of blood monocytes into the artery wall. These antioxidant and antiinflammatory properties of HDL may be as important as its cholesterol efflux function in terms of protecting against the development of atherosclerosis.
引用
收藏
页码:764 / 772
页数:9
相关论文
共 128 条
[1]   Inflammatory/antiinflammatory properties of high-density lipoprotein distinguish patients from control subjects better than high-density lipoprotein cholesterol levels and are favorably affected by simvastatin treatment [J].
Ansell, BJ ;
Navab, M ;
Hama, S ;
Kamranpour, N ;
Fonarow, G ;
Hough, G ;
Rahmani, S ;
Mottahedeh, R ;
Dave, R ;
Reddy, ST ;
Fogelman, AM .
CIRCULATION, 2003, 108 (22) :2751-2756
[2]   Lack of effect of serum amyloid A (SAA) on the ability of high-density lipoproteins to inhibit endothelial cell adhesion molecule expression [J].
Ashby, D ;
Gamble, J ;
Vadas, M ;
Fidge, N ;
Siggins, S ;
Rye, KA ;
Barter, PJ .
ATHEROSCLEROSIS, 2001, 154 (01) :113-121
[3]   Factors influencing the ability of HDL to inhibit expression of vascular cell adhesion molecule-1 in endothelial cells [J].
Ashby, DT ;
Rye, KA ;
Clay, MA ;
Vadas, MA ;
Gamble, JR ;
Barter, PJ .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1998, 18 (09) :1450-1455
[4]  
Auer Johann, 2003, Am J Pharmacogenomics, V3, P317, DOI 10.2165/00129785-200303050-00003
[5]  
Baker PW, 1999, J LIPID RES, V40, P345
[6]  
Baker PW, 2000, J LIPID RES, V41, P1261
[7]   High density lipoproteins (HDLs) and atherosclerosis; the unanswered questions [J].
Barter, P ;
Kastelein, J ;
Nunn, A ;
Hobbs, R .
ATHEROSCLEROSIS, 2003, 168 (02) :195-211
[8]   Effect of high-density lipoproteins on the expression of adhesion molecules in endothelial cells [J].
Barter, PJ ;
Baker, PW ;
Rye, KA .
CURRENT OPINION IN LIPIDOLOGY, 2002, 13 (03) :285-288
[9]   High density lipoproteins and coronary heart disease [J].
Barter, PJ ;
Rye, KA .
ATHEROSCLEROSIS, 1996, 121 (01) :1-12
[10]   Restoration of endothelial function by increasing high-density lipoprotein in subjects with isolated low high-density lipoprotein [J].
Bisoendial, RJ ;
Hovingh, GK ;
Levels, JHM ;
Lerch, PG ;
Andresen, I ;
Hayden, MR ;
Kastelein, JJP ;
Stroes, ESG .
CIRCULATION, 2003, 107 (23) :2944-2948